Changzhou Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHANGZHOU PHARM, and what generic and branded alternatives to CHANGZHOU PHARM drugs are available?
CHANGZHOU PHARM has five approved drugs.
Summary for Changzhou Pharm
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Changzhou Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Changzhou Pharm | CAPTOPRIL | captopril | TABLET;ORAL | 214442-001 | Jan 27, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Changzhou Pharm | PREGABALIN | pregabalin | CAPSULE;ORAL | 214322-007 | Jul 15, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Changzhou Pharm | PREGABALIN | pregabalin | CAPSULE;ORAL | 214322-004 | Jul 15, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Changzhou Pharm | PREGABALIN | pregabalin | CAPSULE;ORAL | 214322-006 | Jul 15, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Changzhou Pharm | PREGABALIN | pregabalin | CAPSULE;ORAL | 214322-008 | Sep 26, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Changzhou Pharm | PREGABALIN | pregabalin | CAPSULE;ORAL | 214322-001 | Jul 15, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Changzhou Pharm | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207408-002 | Oct 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
